I. Core Positioning & Intelligent Collaboration Logic
In the upstream process of cell therapy, the fermentation and preparation stage is the core link for scaling cells from laboratory small‑batch culture to industrial‑scale expansion. It mainly achieves high‑density, high‑activity fermentation expansion of therapeutic cells (e.g., CAR‑T cells, stem cells, immune cells, etc.), providing sufficient and qualified cell raw materials for downstream purification, quality control, and formulation.
As the core carrier of this stage, the core equipment for fermentation and preparation undertakes key functions such as cell fermentation environment regulation, nutrient supply, and metabolite control. It is the core support for ensuring fermentation efficiency, cell quality, and batch consistency, and directly determines the industrialization level of the upstream process.
Devoxin breaks the limitation of “standalone operation” in traditional equipment, deeply integrating such core equipment into an upstream‑downstream integrated intelligent platform to build a four‑in‑one collaboration system of “Equipment‑Process‑Data‑Management”.
Based on AI, IoT and other core technologies, the intelligent platform realizes data interconnection and process linkage between fermentation core equipment and downstream purification and formulation equipment. Meanwhile, it integrates a cell culture process database and dynamically optimizes the fermentation process through intelligent algorithms, making the operation of core equipment more aligned with the full‑chain industrialization requirements.
Different from traditional general‑purpose fermentation equipment, its design and functions are optimized around Devoxin’s upstream‑downstream integration strategy and the collaboration needs of the intelligent platform, adapting to high‑standard, large‑scale cell fermentation scenarios. Among them, De'voxin’s 300L stainless steel vaccine fermenter and other core equipment have realized PID automatic control, which can precisely regulate dissolved oxygen by adjusting air flow, stirring speed, tank pressure, and feeding rate, serving as an important component of the upstream fermentation preparation module in the intelligent platform.
Efficient Mixing and Mass Transfer
The core equipment ensures uniform distribution of nutrients (amino acids, glucose, growth factors, etc.) in the fermentation medium through scientific structural design and operation mode, avoiding local nutrient deficiency. It also timely removes harmful metabolites such as lactic acid and carbon dioxide produced during cell fermentation, preventing metabolite accumulation from inhibiting cell growth.
Devoxin’s upstream‑downstream integrated intelligent platform collects real‑time data on nutrient concentration, metabolite content, etc., during fermentation, and adjusts equipment operating parameters via intelligent algorithms to further optimize mixing and mass transfer efficiency. This guarantees that cells maintain a stable and balanced growth microenvironment throughout the fermentation cycle, effectively improving cell expansion efficiency and overall quality.
Low‑Damage Gas Exchange
The core equipment adopts a mild gas exchange method that meets the oxygen demand for cellular respiration and timely discharges carbon dioxide, while minimizing physical damage to cells. It is especially suitable for sensitive cells such as T cells and stem cells, avoiding decreased cell viability and functional abnormalities caused by mechanical damage, thus ensuring the core quality of fermentation products.
Devoxin’s intelligent platform monitors dissolved oxygen concentration in real time, combines cell growth stage data, and intelligently adjusts gas supply parameters to achieve a precise balance between gas exchange efficiency and cell protection, further enhancing fermentation performance.
II. Solving Core Bottlenecks in Upstream Fermentation & Preparation
The core demands of cell therapy upstream fermentation are large‑scale, high‑activity, high‑consistency, and low‑contamination cell expansion. However, inherent defects of traditional fermentation equipment have become key bottlenecks restricting industrialization, mainly in three aspects:
High mechanical damage easily causes cell rupture and reduced viability, impairing product quality.
Open or semi‑open fermentation modes risk microbial contamination and fail to meet strict GMP standards for cell preparation.
Insufficient parameter control accuracy makes precise synchronous regulation of pH, dissolved oxygen, temperature, and other key parameters difficult, leading to poor batch consistency and inability to support industrial‑scale production.
Relying on the upstream‑downstream integrated intelligent platform, Diwoxin has professionally optimized the core upstream fermentation equipment to targetedly resolve the above bottlenecks, achieving organic integration of contamination control, cell protection, and precise parameter regulation. The intelligent platform breaks down data barriers between core equipment and upstream/downstream processes, realizing collaborative control of fermentation, purification, and formulation. By integrating massive process data and optimizing fermentation parameters via intelligent algorithms, it converts equipment advantages into industrial value for the upstream process, providing full‑chain technical support for fermentation and preparation.
III. Core Technical Requirements
1. Low‑Damage Operating Environment
The core equipment must adopt mild operation to minimize physical damage such as shear stress to cells, ensuring cell integrity and high viability during fermentation. This is critical for shear‑sensitive cells including T cells, stem cells, and tumor‑infiltrating lymphocytes. It not only supports normal expansion but also maintains stable expression of key functional proteins, supplying high‑quality cell raw materials for downstream processes and laying a foundation for final product quality. Diwoxin further optimizes equipment operation through real‑time monitoring and fine parameter adjustment via the intelligent platform, minimizing cell damage rate.
2. Closed Single‑Use Fermentation System
Equipped with pre‑sterilized single‑use fermentation carriers and closed pipeline connection systems, all operations are performed in a fully enclosed environment without complex cleaning and sterilization procedures. This design:
Greatly reduces microbial (bacteria, fungi, viruses, etc.) contamination risks and complies with GMP high standards.
Eliminates cross‑contamination between batches and ensures batch consistency.
Reduces maintenance costs and shortens fermentation cycles, improving upstream efficiency.
The system seamlessly connects with Diwoxin’s intelligent platform, enabling full closed‑loop process control and real‑time data uploading for quality traceability and compliance auditing.
3. Precise Fermentation Process Parameter Control
Integrated advanced online monitoring and feedback control units enable real‑time monitoring and precise regulation of key parameters, maintaining an optimal fermentation environment, improving efficiency and batch consistency, and adapting to industrial‑scale production. Based on this, Diwoxin’s intelligent platform realizes intelligent collaborative regulation:
pH: Automatic addition of CO₂ or alkaline solution (e.g., sodium bicarbonate) via cascade control stabilizes pH within the optimal range (typically 2–7.4). The intelligent platform dynamically adjusts parameters according to cell growth to support efficient metabolism and reduce inhibitory byproducts.
Dissolved Oxygen (DO): Precisely regulates gas environment (oxygen concentration, ventilation rate). The intelligent platform automatically adjusts DO according to metabolic demands at different stages (lag phase, logarithmic phase, stationary phase). Diwoxin’s 300L stainless steel vaccine fermenter achieves precise DO control via PID by adjusting air flow, stirring speed, and other parameters to meet oxygen supply for high‑density cell expansion.
Temperature & Operating Parameters: High‑precision temperature control stabilizes at approximately 37°C (human physiological temperature) to simulate the in vivo environment. The intelligent platform automatically optimizes operating parameters according to fermentation progress, balancing mixing efficiency, gas exchange, and shear control for a stable physical environment.
4. Compliance & Scalability
The control software complies with international data integrity regulations such as 21 CFR Part 11, with complete audit trail functions. All parameter changes and operations are recorded in real time and synchronized to the intelligent platform for quality review and regulatory verification, meeting compliance requirements. Multiple fermentation volumes (10L to 50L and above) are available, supporting perfusion, batch, and other fermentation modes. It enables linear scale‑up from lab development to pilot and industrial production, seamlessly matching the large‑scale fermentation demands of Diwoxin’s intelligent platform, providing flexible and efficient equipment support for upstream industrialization.
IV. Application Scenarios in Fermentation & Preparation
Supported by Diwoxin’s upstream‑downstream integrated intelligent platform, core upstream fermentation equipment has been widely applied in multiple cell therapy scenarios with professional design and precise regulation:
Immune Cell Fermentation (CAR‑T, TCR‑T, etc.)
For CAR‑T, TCR‑T and other immune cells, the low‑damage environment maintains T‑cell activity and proliferation. The intelligent platform ensures phenotypic uniformity, achieving large‑scale expansion of functional, homogeneous effector T cells to meet dosage requirements for downstream processes while improving upstream efficiency and product quality.
Stem Cell Fermentation
Stem cells (mesenchymal stem cells, pluripotent stem cells) require extremely strict environments. The equipment provides a mild, stable environment; the intelligent platform monitors growth status and optimizes parameters in real time to effectively maintain stemness and differentiation potential, supporting large‑scale, high‑quality expansion.
Other Somatic Cell Fermentation
Suitable for tumor‑infiltrating lymphocytes, fibroblasts, and other somatic cells. For example, in TIL preparation, the equipment achieves high‑efficiency expansion; the intelligent platform manages the whole process to maintain tumor‑killing activity, providing qualified raw materials and promoting industrialization of somatic cell therapy.
in conclusion：Industrialization Breakthrough of Upstream Fermentation Equipment for Cell Therapy Empowered by Intelligent Platform
Core equipment for upstream fermentation and preparation is the cornerstone of large‑scale development in cell therapy. Empowered by Diwoxin’s upstream‑downstream integrated intelligent platform, it features low‑damage operation, closed design, precise parameter control, compliance, and scalability, perfectly matching the core demands of “large‑scale, high‑activity, high‑consistency, low‑contamination” fermentation. It effectively overcomes inherent bottlenecks of traditional equipment.
Diwoxin’s intelligent platform further strengthens compatibility between equipment, upstream fermentation, and downstream modules, connecting the full chain from lab to industrial production, integrating equipment, process, and data resources. It is a critical guarantee for breaking scale bottlenecks, reducing costs, and improving product quality, laying a solid foundation for the industrialization of cell therapy upstream processes.
